Table 2.
Territories, mechanism, and revascularization of ischemic strokes
| COVID- (n = 176) | COVID+ (n = 40) | p value | Test | |
|---|---|---|---|---|
| Stroke territories, n (%) | ||||
| Anterior cerebral artery, n | 18 (10) | 9 (23) | 0.058 | Fischer |
| Middle cerebral artery, n | 109 (63) | 20 (51) | 0.18 | χ2 |
| Posterior cerebral artery, n | 25 (14) | 7 (18) | 0.58 | χ2 |
| Basilar artery, n | 28 (16) | 6 (15) | 0.9 | χ2 |
| Multiple territory, n | 25 (14) | 10 (26) | 0.089 | χ2 |
| Stroke mechanism, n (%) | ||||
| Large-artery atherosclerosis, n | 44 (26) | 9 (22) | 0.69 | χ2 |
| Cardioembolism, n | 56 (33) | 10 (25) | 0.33 | χ2 |
| Small-vessel occlusion, n | 13 (7.6) | 1 (2.5) | 0.48 | Fischer |
| Other, n | 5 (2.9) | 3 (7.5) | 0.18 | Fischer |
| Undetermined, n | 61 (35) | 18 (45) | 0.26 | χ2 |
| Revascularization procedures, n (%) | ||||
| Thrombectomy, n | 29 (16) | 11 (28) | 0.11 | χ2 |
| Alteplase, n | 24 (14) | 9 (22) | 0.16 | χ2 |